Training for Speech and Hearing Sciences

项目总结/摘要 这项建议延长了为期五年的跨学科博士课程开始于1992年，演讲和 听力生物科学与技术（SHBT）计划，该计划为科学家在美国的创新研究事业做好准备。 言语与听觉科学培训的目的是显著提高演讲和听力的领导潜力 学术界、工业界和制定科学政策的组织中的研究人员。该计划的基本前提是 今天的语言和听力科学家必须精通各种物理，生物，临床和认知 科学学科，以实现多学科的进步，推动创新。该计划的基石是 严格的核心课程，向学员介绍这四个方面的言语和听力。该方案借鉴 波士顿地区各机构，包括哈佛医学院、麻省理工学院、波士顿 大学和马萨诸塞州总医院卫生保健研究所（MGH-IHP）。 迄今为止，已有近140名学生从SHBT毕业并获得博士学位。学员有不同的本科 在物理，工程，生物或认知科学的背景，包括一些与传统的讲话， 听力背景和AUD学位。培训结合了前两年的课程和研究轮换 之后，它专注于论文研究，预计在5至6年后获得博士学位。课业 研究训练结合了与言语和听力相关的许多科学学科的广泛接触 同时对学生选择的研究领域有深入的了解。沉浸式临床接触， 马萨诸塞州的眼睛和耳朵是教学培训计划的一大亮点。特别注意诚信问题 负责任地进行研究，并进行方法培训，以提高研究的可重复性。一个独特 与MGH-IHP的合作使感兴趣的学员能够满足语音临床认证的要求- 语言病理学课程和临床实习。 在过去五年中，我们从代表性不足的少数民族中招聘学员的能力大大提高。 这些努力正在通过最近任命的多样性，公平和 包容性、旨在提高公平性的入学程序改革以及增加招聘活动。 我们的140名毕业生中的绝大多数都在从事医疗保健方面的研究或研究相关的职业， 这些机构主要从事言语和听力科学方面的活动。许多人在基础科学方面有教职， 工程和临床部门，并领导有影响力的研究计划，并成功地竞争 研究赠款金有些人将耳科、神经病学、听力学或语言学的研究生涯与临床实践相结合， 语言病理学有些人在与演讲和听力相关的行业或更广泛的行业中担任领导角色 生物技术领域，他们正在开发用于交流障碍的辅助设备和药物治疗， 听力损失

Project Summary/ Abstract This proposal extends for a period of five years an interdisciplinary doctoral program begun in 1992, the Speech and Hearing Bioscience and Technology (SHBT) program, which prepares scientists for innovative research careers in the Speech and Hearing Sciences. Training is intended to enhance markedly the leadership potential of Speech and Hearing researchers within both academia, industry, and organizations that set science policy. The basic premise of the program is that today’s speech and hearing scientists must be fluent in a variety of physical, biological, clinical and cognitive science disciplines to achieve the multidisciplinary advances that drive innovation. A keystone of the program is a rigorous Core Curriculum that introduces trainees to these four aspects of speech and hearing. The program draws upon the combined expertise of the faculties of Boston area institutions, including the Harvard Medical School, MIT, Boston University and the Massachusetts General Hospital Institute of Health Professions (MGH-IHP). To date, nearly 140 students have graduated with a PhD from SHBT. Trainees have diverse undergraduate backgrounds in the physical, engineering, biological or cognitive sciences, including some with traditional speech and hearing backgrounds and AuD degrees. Training combines coursework and research rotations for the first two years after which it concentrates on dissertation research, with the PhD degree expected after 5 to 6 years. The coursework and research training combines a broad exposure to the many scientific disciplines relevant to speech and hearing together with a deep understanding of the student’s chosen research area. An immersive clinical exposure at Massachusetts Eye and Ear is a highlight of the didactic training program. Special attention is given to issues of integrity and responsible conduct of research as well as training in methods to enhance reproducibility in research. A unique collaboration with the MGH-IHP allows interested trainees to meet the requirements for clinical certification in speech- language pathology through classes and clinical placements at this institution. Our ability to recruit trainees from underrepresented minorities has significantly increased over the past five years. These efforts are being further enhanced through the recent appointment of a faculty Director of Diversity, Equity and Inclusion, changes in admission procedures aimed at greater equity, and increased recruiting activities. A vast majority of our 140 graduates are pursuing research or research-related careers in health care, and half of these have primary activities in the speech and hearing sciences. Many have faculty positions in basic science, engineering, and clinical departments and are leading impactful research programs and successfully competing for research grants. Some are combining research careers with clinical practice in otology, neurology, audiology or speech- language pathology. Some are taking leadership roles in industries related to speech and hearing or in the broader biotechnology field where they are developing assistive devices for communication disorders and drug therapies for hearing loss.